Researchers Develop Assay for Predicting Lung Cancer Drug Response
August 27, 2009
Researchers Develop Assay for Predicting Lung Cancer Drug Response
A team of investigators from the UK and New Zealand has demonstrated that expression changes in known or predicted drug response genes correspond to chemotherapy response in non-small cell lung cancer tumor samples.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Transgenomic, Amgen Ink Deal to Develop Test for KRAS, NRAS
May 6, 2013 / GenomeWeb Daily News - FDA Issues Emergency Use Authorization for PCR-based A(H7N9) Influenza Virus Assay
April 24, 2013 / GenomeWeb Daily News - Life Tech Acquisition Would Make Thermo Fisher a Leader in PCR Research Tools, Forensic Analysis
April 18, 2013 / PCR Insider - Grifols Acquires 60 Percent Stake in Progenika
March 7, 2013 / GenomeWeb Daily News - Saladax, Transmedic Partner to Distribute Oncology Dosing Assays in Singapore, Hong Kong
February 18, 2013 / GenomeWeb Daily News